Interventional Cardiology Journal Open Access

  • ISSN: 2471-8157
  • Journal h-index: 5
  • Journal CiteScore: 0.33
  • Journal Impact Factor: 0.26
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Reach us +32 25889658

Thrombotic and bleeding risks: how best to balance in real world

2nd Edition of EuroSciCon Congress on Heart Disease and Interventional Cardiology
February 25-26, 2019 | Paris, France

Syed Raza

Awali Hospital, Bahrain

Posters & Accepted Abstracts: Interv Cardiol J


Antithrombotic therapy has revolutionized the medical management of patients. Over the past 20 years, the development of new antithrombotic medications and strategies has reduced ischemic events very significantly. With every approach to reduce thrombosis, however, there is an accompanying risk of increasing bleeding complications. Conversely, reducing bleeding complications may increase thrombotic (ischemic) events. Due to increasing number of elderly population, prevalence of thrombosis related complications and bleeding associated with anti-thrombotic treatment is constantly rising. There are various tools to assess thrombotic risk but assessment of bleeding risk is often ignored. Thrombosis and bleeding both increase morbidity and mortality. Balancing both ends of the spectrum is essential and an individualized approach to therapy is advocated. The author will present various strategies to balance the thrombotic and bleeding risk assessment and management. This presentation will be of interest to physicians, cardiologists, haematologists, surgeons, anaesthetists and nurses.

Biography :